Lantheus Q4 2023 rev $354M (+34.5%), adj EPS $1.75; FY2024 guidance raised

Lantheus Holdings, Inc.

2023-FY EPS reported $4.65 revenue$1,296,429,000

Q4 2023 revenue $354M (+34.5% YoY), including $15M RELISTOR milestone; FY2023 revenue $1.3B (+38.6% YoY).
GAAP net income Q4 $103.4M ($1.47) vs loss of $119.2M (-$1.74) in Q4 2022; FY net income $326.7M ($4.65).
Adjusted diluted EPS Q4 $1.75 (+28% YoY); FY2023 $6.23 (+47.7% YoY).
FY2024 guidance: revenue $1.41-1.445B, adjusted EPS $6.50-6.70 (above FY2023 $6.23).
Free cash flow FY2023 $258.7M; net cash from ops $305.3M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.97

Lantheus Holdings, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $354.0 million and $1.3 billion, net income $103.4 million and $326.7 million, EPS $1.47 and $4.65 per fully diluted share. Guidance initiated.

Period: the fourth quarter and full year ended December 31, 2023
Revenue: $354.0 million and $1.3 billion
Net income: $103.4 million and $326.7 million
EPS: $1.47 and $4.65 per fully diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results • Worldwide revenue of $354.0 million and $1.3 billion for the fourth quarter and full year 2023 • GAAP net income of $103.4 million and $326.7 million for the fourth quarter and full year 2023 • GAAP fully diluted net income per share of $1.47 and $4.65 for the fourth quarter and full year 2023

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

Lantheus Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-006157

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.